SCHEMBL5575807

SCHEMBL5575807

NC(=O)CCCCCCCCCCCCCO

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.60
FFAR1 O14842 1/20 0.60
FFAR4 Q5NUL3 1/20 0.60
KDM4E B2RXH2 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SOAT1 P35610 2/20 0.44
FAAH O00519 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
CAMK2A Q9UQM7 1/20 0.43
LMNA P02545 5/20 0.40
TSHR P16473 2/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28624684 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL95430 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
1,6-Hexanediol SCHEMBL28628065 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL7554526 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL2839590 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL8411317 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL1479946 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL5575804 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL2011125 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL6924277 1.00 GPR84 (0.60) GPR84FFAR1FFAR4KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3934639-A1 FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN Epitracker, Inc. (US) 2022-01-12 EP disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed
US-5599483-A FOAMABLE CLEASING COMPOUND FOR HAIR, SKIN; STABILITY KAO CORPORATION (JP) 1997-02-04 US disclosed